Skip to main content

Cingulate Inc.

CINGW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001862150

No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.88K in total; no superinvestor holds it.

Other share classesCING

Q1 2022 vs. Q4 2021

How the institutions holding Cingulate Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CINGW: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders770
Shares2.12M2.23M+109.1K (+5.2%)
Value$1.22M$826.0K−$391.0K (−32.1%)

New holders (0)

Institutions that held Cingulate Inc. at the end of Q1 2022 but not at the end of Q4 2021.

None.

Sold out (0)

Institutions that held Cingulate Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

None.